XENE · Xenon Pharmaceuticals Inc.
Market Cap
$5.81B
Shares
96.84M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-06 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-02 | Xenon Pharmaceuticals Annual Meeting of Shareholders | Shareholder meeting |
| 2026-05-19 | RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-14 | Bank of America Global Healthcare Conference | Conference |
| 2026-05-07 | Q1 2026 Xenon Pharmaceuticals Inc. Earnings Conference Call | Earnings call |
| 2026-04-22 | Bloom Burton & Co. Healthcare Investor Conference | Conference |
| 2026-03-09 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-09 | Phase 3 X-TOLE2 Study Topline Results | Event |
| 2026-01-12 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-10 | Azetukalner and Epilepsy Data Update: AES 2025 | Event |
| 2025-11-19 | Jefferies Global Healthcare Conference | Conference |
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
279 filings
266 filers
Visit website
Investor relations